Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00987
|
|||||
| Drug Name |
Gamma-hydroxybutyric acid
|
|||||
| Synonyms |
3-carboxypropoxy acid; 4 HB; 4-Hydroxy; 4-Hydroxyacid; 4-Hydroxyalkanoic acid; 4-Hydroxybutanoic acid; 4-Hydroxybuttersaeure; 4-Hydroxybutyrate sodium; 4-Hydroxybutyric acid; 4-Hydroxybutyric acid monosodium salt; 4-Hydroxycarboxylic acid; 4-OHB; 4-hydroxy-butyric acid; AA3E2AF0-AB7A-4A1E-A391-199C049D7162; Anetamin; Butanoic acid, 4-hydroxy-, monosodium salt; Butanoic acid, 4-hydroxy-, sodium salt; Butyric acid, 4-hydroxy-, monosodium salt; Butyric acid, 4-hydroxy-, sodium salt; EB 27; GHB; Gam-OH; Gamma OH; Gamma-Hydroxy butyrate; Gamma-Hydroxy sodium butyrate; Gamma-Hydroxybutanoic acid; Gamma-Hydroxybutyrate sodium; Gamma-Hydroxybutyric acid; Gamma-Hydroxybutyric acid decomposition product; Gamma-Hydroxybutyric acid monosodium salt; Gamma-Hydroxybutyric acid, sodium salt; Gamma-OH; Hydroxyb; Oxy-n-butyric acid; Oxybate; Oxybate sodium; SHB; Sodium .gamma.-hydroxybutyrate; Sodium .gamma.-oxybutyrate; Sodium Oxybate (4-hydroxybutanoic acid); Somsanit; Utyric acid monosodium salt; WY 3478; Xyrem; Xyrem (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Cerebrovascular disorder [ICD11: 8B2Z] | Approved | [1] | |||
| Therapeutic Class |
Anesthetics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C4H8O3
|
|||||
| Canonical SMILES |
C(CC(=O)O)CO
|
|||||
| InChI |
InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7)
|
|||||
| InChIKey |
SJZRECIVHVDYJC-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 591-81-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 104.1 | Topological Polar Surface Area | 57.5 | ||
| Heavy Atom Count | 7 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
-0.6
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:30830
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MCT1 | Transporter Info | Monocarboxylate transporter 1 | Substrate | [2] | |
| SMCT2 | Transporter Info | Sodium-coupled monocarboxylate transporter 2 | Substrate | [3] | ||
| References | ||||||
| 1 | Gamma-hydroxybutyric acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab Dispos. 2007 Feb;35(2):201-8. | |||||
| 3 | Sodium-coupled monocarboxylate transporters in normal tissues and in cancer. AAPS J. 2008;10(1):193-9. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.